Successful management of a patient with Marfan syndrome complicated with acute aortic dissection using landiolol during Cesarean section

Journal of Anesthesia

Volumn 24, Issue 2, 2010, Pages 277-279

  Saeki, Noboru ^a   Taguchi, Shima ^a   Kawamoto, Masashi ^a  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Aortic dissection; Cesarean section; Landiolol; Marfan syndrome

Indexed keywords

BUPIVACAINE; ERGOMETRINE; GLYCERYL TRINITRATE; LANDIOLOL; NICARDIPINE; OXYTOCIN;

ADULT; AORTA DISSECTION; ARTICLE; BACKACHE; BLOOD PRESSURE; CASE REPORT; CESAREAN SECTION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HALF LIFE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EMERGENCY SURGERY; EPIDURAL ANESTHESIA; FEMALE; GESTATIONAL AGE; HEART LEFT VENTRICLE CONTRACTION; HEART RATE; HEMODYNAMICS; HUMAN; KIDNEY BLOOD FLOW; MARFAN SYNDROME; MITRAL VALVE REGURGITATION; PATIENT CARE; POSTOPERATIVE PERIOD; PREGNANT WOMAN; SINUS RHYTHM; SPINAL ANESTHESIA; UTERUS CONTRACTION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANEURYSM, DISSECTING; AORTIC ANEURYSM; BLOOD PRESSURE; CESAREAN SECTION; FEMALE; HEART RATE; HUMANS; MARFAN SYNDROME; MORPHOLINES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TACHYCARDIA; TREATMENT OUTCOME; UREA; UTERINE CONTRACTION;

EID: 77954537903     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-009-0859-8     Document Type: Article

References (20)

1. Silverman DI, Burton KJ, Grey J, Bosner MS, Kouchoukos NT, Roman MJ, et al. Life expectancy in the Marfan syndrome. Am J Cardiol. 1995;75:157-160
2. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyerits RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173:1599-1606
3. Lipscomb KJ, Smith JC, Clarke B, Donnai P, Harris R. Outcome of pregnancy in woman with Marfan's syndrome. Br J Obstet Gynecol. 1997;104:201-206
4. Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and treatment. N Engl J Med. 1979;300:772-777
5. The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J. 24:761-781
6. Gersony DR, McClaughlin MA, Jin Z, Gersony WM. The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis. Int J Cardiol. 2007; 114:303-308
7. Kashanian M, Fekrat M, Zarrin Z, Ansari NS. A comparison between the effect of oxytocin only and oxtocin plus propranolol on the labor (a double blind randomized trial). J Obstet Gynaecol Res. 2008;34:354-358
8. Kamata K, Morioka N, Nomura M, Ozaki M. Short-acting beta 1-adrenergic blocker is useful for anesthetic management of Cesarean section in a patient with Marfan syndrome (in Japanese with English abstract). Masui (Jpn J Anesthesiol). 2004;53:298-301.
9. Oskoui R, Lindsay J. Aortic dissection in women\40 years of age and the unimportance of pregnancy. Am J Cardiol. 1994; 73:821-823
10. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256:H1060-5.
11. Manalo-Estrella P, Barker AE. Histopathologic findings in human aortic media associated with pregnancy. Arch Pathol. 1967;83:336-341
12. Meijboom LJ, Vos FE, Timmermans J. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J. 2005;26:914-920 (Pubitemid 40676572)
13. Handa F, Ohnishi Y, Takauchi Y, Kuro M. Anesthetic management of parturients with Marfan syndrome (in Japanese with English abstract). Masui (Jpn J Anesthesiol). 2001;50:399-404.
14. Katz J, Benumof JL, Leslie B, Kadis LB. Marfan's syndrome. In: Anesthesia and uncommon disease, 3rd edn. Philadelphia: Saunders; 1990. pp 144-145 (see also pp 294-5).
15. Pyeritz RE, Fishman EK, Bernhardt BA, Siegelman SS. Dural ectasia is a common feature of the Marfan syndrome. Am J Hum Genet. 1988;43:726-732
16. Cook TM. Combined spinal-epidural techniques. Anaesthesia. 2000;55:42-64.
17. Kodama K, Nishigami K, Sakamoto T, Sawamura T, Hirayama T, Misumi H, et al. Tight heart rate control reduces secondary adverse events in patients with type B acute aortic dissection. Circulation. 2008;118(suppl 1):S167-70.
18. Nishimura T, Chihara N, Shirakawa R, Sugai S, Sakamoto T, Nakagawa Y, et al. Reproductive and developmental toxicity studies of landiolol hydrochloride (ONO-1101) (4). Perinatal and post natal study in rats. J Toxicol Sci. 1997;22:537-557 (Pubitemid 28032272)
19. Shiroya T, Ichioka Y, Yoshida K, Nishijima K, Oosako N, Naka M, et al. Pharmacological studies of ONO-1101 as a betablocking agent with high beta-1 selectivity and ultra-short duration of action. Kiso Rinsho. 1997;31:2913-2923
20. Ikeshita K, Nishikawa K, Toriyama S, Yamashita T, Tani Y, Yamada T, et al. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J Anesth. 2008; 22:361-366